✦ LIBER ✦

Anticancer drugs: Blocking phospholipid–protein interactions

✍ Scribed by Harrison, Charlotte

Book ID: 109951272
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 147 KB
Volume: 10
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd3343

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction of an anticancer drug, gemci

Interaction of an anticancer drug, gemcitabine, with phospholipid bilayers

✍ Barbara Pili; Claudie Bourgaux; Florian Meneau; Patrick Couvreur; Michel Ollivon 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 573 KB

Drugs Targeting Protein—Protein Interact

Drugs Targeting Protein—Protein Interactions

✍ Patrick Chene 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Drugs Targeting Protein–Protein Interact

Drugs Targeting Protein–Protein Interactions

✍ Patrick Chène 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Application of NMR and UV spectroscopy i

Application of NMR and UV spectroscopy in the study of interactions between anticancer drugs and their phospholipid carriers

✍ Danuta Pentak; Anna Sułkowska; Wiesław W. Sułkowski 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 618 KB

Interaction of the anticancer agent Taxo

Interaction of the anticancer agent Taxol? (paclitaxel) with phospholipid bilayers

✍ Bernsdorff, Corinna ;Reszka, Regina ;Winter, Roland 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Taxol™ (paclitaxel) , a promising agent for use in ovarian and breast cancer, was incorporated into lipid vesicles (liposomes) composed of different saturated and unsaturated phosphatidylcholines, as well as saturated phosphatidylcholines mixed with the anionic phospholipid 1,2-dimyristoyl-sn-glyce

Clinically relevant drug interactions be

Clinically relevant drug interactions between anticancer drugs and psychotropic agents

✍ K.Y.-L. YAP; W.L. TAY; W.K. CHUI; A. CHAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB